| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.65 | 0.01 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.01 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.01 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.073 | 0.01 |